Screening Non Small Cell Lung Cancer With Bone Metastasis and Efficacy and Safety Research of Receiving Bisphosphonates

PHASE4CompletedINTERVENTIONAL
Enrollment

432

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
Non-small Cell Lung CancerBone Metastases
Interventions
DRUG

bisphosphates

any bisphosphate, repeated every 4 weeks for up to 24 months. Co-administration with Zometa: Calcium 500 mg + vitamin D 400-500 IU daily

Trial Locations (1)

Unknown

SunYat-senU, Guangzhou

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Sun Yat-sen University

OTHER